Jama, Kimhar S.

HRN: 22-28-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CEFTRIAXONE 1G (VIAL)
12/07/2022
12/13/2022
IV
2gm
Q24
CAP MR
Waiting Final Action 
12/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/09/2022
12/16/2022
IV
500mg
Q8
CAP MR, Setic Shock, Intraabdominal Infection
Waiting Final Action 
12/10/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/10/2022
12/16/2022
IV
4.5g
Q6H
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: